SCHEMBL23328367

SCHEMBL23328367

O=C(NCS(=O)(=O)O)Nc1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACP1 P24666 2/20 0.59
EPHX1 P07099 5/20 0.57
TP53 P04637 2/20 0.57
SMN1; SMN2 Q16637 2/20 0.57
TSHR P16473 1/20 0.57
EPHX2 P34913 1/20 0.57
CDK9 P50750 1/20 0.57
CLK4 Q9HAZ1 1/20 0.57
HTT P42858 2/20 0.54
ALDH1A1 P00352 1/20 0.54
CA1 P00915 4/20 0.53
CA2 P00918 4/20 0.53
KDM4E B2RXH2 1/20 0.51
HDAC1 Q13547 1/20 0.51
HDAC8 Q9BY41 1/20 0.51
HDAC6 Q9UBN7 1/20 0.51
CA12 O43570 3/20 0.50
CA9 Q16790 3/20 0.50
NPC1 O15118 2/20 0.50
RAB9A P51151 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23329075 0.82 SAE1 (0.50) TSHRCA1CA2KDM4ECA12
SCHEMBL25840768 0.82 NPC1 (0.60) TP53SMN1; SMN2ALDH1A1CA1CA2
SCHEMBL23328727 0.82 RAB9A (0.60) EPHX1CA1CA2CA12CA9
SCHEMBL10278172 0.80 EPHX1 (0.65) ACP1EPHX1TP53SMN1; SMN2HTT
SCHEMBL9362015 0.80 KDM4E (0.47) SMN1; SMN2ALDH1A1CA1CA2KDM4E
SCHEMBL9365783 0.80 FPR2 (0.46) ACP1EPHX2ALDH1A1CA1CA2
SCHEMBL23328402 0.79 EPHX1 (0.56) EPHX1SMN1; SMN2HTTALDH1A1CA1
SCHEMBL23328674 0.78 HDAC3 (0.58) EPHX1TP53SMN1; SMN2TSHRALDH1A1
SCHEMBL8214915 0.78 SAE1 (0.58) EPHX1TSHREPHX2HTTALDH1A1
SCHEMBL23328365 0.78 FPR2 (0.67) EPHX2CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-11701333-B2 Antibacterial compounds Kent Innovation & Enterprise (GB) 2023-07-18 US disclosed
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS KENT INNOVATION & ENTERPRISE, UNIVERSITY OF KENT (GB) 2021-05-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11701333-B2 Antibacterial compounds ARF1, ARL1, TLR1 ACP1 4001/4885EPHX1 2158/4885TP53 4494/4885
US-20210128501-A1 ANTIBACTERIAL COMPOUNDS ARF1, ARL1, TLR1 ACP1 4001/4885EPHX1 2158/4885TP53 4494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.